Chemoinformaics analysis of 3,7-DIMETHYL-4,5,6,9-TETRAHYDROCOUMARAN
| Molecular Weight | 152.237 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 10 |
| Exact Molecular Weight | 152.12 | nRing | 2 |
| Solubility: LogS | -2.766 | nHRing | 1 |
| Solubility: LogP | 2.731 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 17.7873 |
| QED | 0.484 |
| Synth | 4.288 |
| Natural Product Likeliness | 2.411 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.444 |
| MDCK | 0.0000224 |
| BBB | 0.589 |
| PPB | 0.889326 |
| VDSS | 1.525 |
| FU | 0.0887473 |
| CYP1A2-inh | 0.151 |
| CYP1A2-sub | 0.684 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.039 |
| CYP2c9-sub | 0.104 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.54 |
| CYP3a4-inh | 0.05 |
| CYP3a4-sub | 0.355 |
| CL | 7.667 |
| T12 | 0.213 |
| hERG | 0.021 |
| Ames | 0.711 |
| ROA | 0.052 |
| SkinSen | 0.101 |
| Carcinogencity | 0.674 |
| EI | 0.844 |
| Respiratory | 0.198 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.937052 |